Sign in
Active, not recruitingPhase 4

the PHENOSAR Trial: Use of Antibiotics in Treatment of Sarcoidosis

Key facts

Who runs it
St. Antonius Hospital
Where
Netherlands1 site in 1 countryChoose a country to see its sites
Status
Active, not recruiting
Phase
Phase 4
People taking part
40 people, planned
Started
15 Feb 2023
Expected to end
1 Dec 2026
Type of study
Interventional, 4 groupsOne group gets an existing treatment, for comparison.
Treatments tested
  • FDG-PET/CT
Record updated
12 February 2026

Who can take part

Age
18 years and older
Sex
Women and men
Healthy volunteers
Cannot take part

The registry criteria, word for word

Show all 7 criteriaShow less

Who can take part

  • Biopsy proven sarcoidosis
  • No treatment indication for the sarcoidosis
  • Inflammatory activity according to FDG-PET scan at baseline
  • SUVmax above 3 in the lung and/or above 5 in mediastinum/hili

Who cannot take part

  • Increased duration of QT interval (>440ms for men and >450ms for women) on ECG
  • Hearing deficits, as this is a possible side effect of azithromycin
  • Being pregnant or breastfeeding at time of inclusion

Where is this trial?

It has sites in one country. Choose a country to see its sites.

About the trial

What the trial wants to find out

In this study it is investigated whether treatment with azithromycin in combination with doxycycline reduces the bacterial load of C. acnes in granulomatous tissue of patients with sarcoidosis and subsequently decreases the inflammatory activation measured by FDG uptake and serum biomarkers.

The 4 groups in the trial

  • C Acnes present in granulomatous tissue, treatment with antibioticsExisting treatment, for comparison

    patients who are in this arm will receive azithromycin and doxycycline for 3 months

    Treatment: FDG-PET/CT

  • C Acnes present in granulomatous tissue, treatment with placeboPlacebo, for comparison

    patients who are in this arm will receive placebo for 3 months

    Treatment: FDG-PET/CT

  • C Acnes NOT present in granulomatous tissue, treatment with antibioticsExisting treatment, for comparison

    patients who are in this arm will receive azithromycin and doxycycline for 3 months

    Treatment: FDG-PET/CT

  • C. Acnes NOT present in granulomatous tissue, treatment with placeboPlacebo, for comparison

    patients who are in this arm will receive placebo for 3 months

    Treatment: FDG-PET/CT

Data and sources

Registry record
Listed on ClinicalTrials.gov and on the EU's official list of trials (CTIS).How to verify a trial in the registry
Official title
PHENOtype Based Therapy With Antibiotics in SARcoidosis Patients With and Without Presence of Cutibacterium Acnes in Granulomatous Tissue
Record updated
12 February 2026